Natsuko T. Okita

Tokyo, 1040045, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 84 publications

Recommendations for generating real-world evidence with regulatory-grade relevance and reliability.

Recommendations for generating real-world evidence with regulatory-grade relevance and reliability.

Journal: International journal of clinical oncology

Published: June 09, 2026

Proteinuria as the cause of early dose modification in Japanese patients with metastatic colorectal cancer treated with fruquintinib: a multicenter real-world study.

Proteinuria as the cause of early dose modification in Japanese patients with metastatic colorectal cancer treated with fruquintinib: a multicenter real-world study.

Journal: International journal of clinical oncology

Published: May 28, 2026

ENVELOPE: enfortumab vedotin in patients with advanced small bowel adenocarcinoma refractory or intolerant to platinum-based therapy-phase II investigator-initiated trial (NCCH2412/MK015).

ENVELOPE: enfortumab vedotin in patients with advanced small bowel adenocarcinoma refractory or intolerant to platinum-based therapy-phase II investigator-initiated trial (NCCH2412/MK015).

Journal: ESMO gastrointestinal oncology

Published: April 20, 2026

Efficacy of Pazopanib for a Patient with FGFR1-Amplified Breast Cancer: A Case Report.

Efficacy of Pazopanib for a Patient with FGFR1-Amplified Breast Cancer: A Case Report.

Journal: Case reports in oncology

Published: February 20, 2026

Comprehensive Genomic Profiling of Advanced Anal Adenocarcinoma in Japan.

Comprehensive Genomic Profiling of Advanced Anal Adenocarcinoma in Japan.

Journal: JCO precision oncology

Published: January 15, 2026

First-in-human phase I study of hypoxia-targeting 64Cu-ATSM radioligand therapy in patients with malignant brain tumors (STAR-64).

First-in-human phase I study of hypoxia-targeting 64Cu-ATSM radioligand therapy in patients with malignant brain tumors (STAR-64).

Journal: ESMO open

Published: January 04, 2026

Feasibility of antibiotic-assisted fecal microbiota transplantation with immunotherapy for esophageal and gastric cancer.

Feasibility of antibiotic-assisted fecal microbiota transplantation with immunotherapy for esophageal and gastric cancer.

Journal: Future oncology (London, England)

Published: December 17, 2025

Retrospective Comparison of Capecitabine plus Oxaliplatin and Docetaxel plus S-1 as Adjuvant Chemotherapy for Pathological Stage III Gastric Cancer.

Retrospective Comparison of Capecitabine plus Oxaliplatin and Docetaxel plus S-1 as Adjuvant Chemotherapy for Pathological Stage III Gastric Cancer.

Journal: Oncology

Published: November 07, 2025

Prognostic Impact of Claudin18.2 and TROP2 Expression in Advanced Gastric Cancer Treated With Nivolumab.

Prognostic Impact of Claudin18.2 and TROP2 Expression in Advanced Gastric Cancer Treated With Nivolumab.

Journal: Anticancer research

Published: October 21, 2025

Early Mycophenolate Mofetil Combination Therapy as an Effective Approach for Immune-Related Hepatitis Induced by Immune Checkpoint Inhibitors in Patients With Solid Tumor.

Early Mycophenolate Mofetil Combination Therapy as an Effective Approach for Immune-Related Hepatitis Induced by Immune Checkpoint Inhibitors in Patients With Solid Tumor.

Journal: Cancer medicine

Published: September 17, 2025

Phase I study of pevonedistat combined with capecitabine and oxaliplatin in patients with platinum-refractory advanced gastric cancer.

Phase I study of pevonedistat combined with capecitabine and oxaliplatin in patients with platinum-refractory advanced gastric cancer.

Journal: Scientific reports

Published: May 25, 2025

Association Between Immune-Related Adverse Events and Treatment Outcomes in Advanced Gastric Cancer Patients Receiving Nivolumab Plus Chemotherapy: A Retrospective Study.

Association Between Immune-Related Adverse Events and Treatment Outcomes in Advanced Gastric Cancer Patients Receiving Nivolumab Plus Chemotherapy: A Retrospective Study.

Journal: Cancer medicine

Published: January 23, 2025

Showing 1-12 of 84

Last Updated: 09/26/2026